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Retrospective study of owners’ perception on home 
monitoring of blood glucose in diabetic  
dogs and cats
I. Van de Maele, N. Rogier, S. Daminet
Abstract — Home monitoring of blood glucose (HMBG) concentrations has been recommended 
in the monitoring of human diabetics for 3 decades. During the last number of years, it also gained 
popularity in long-term follow-up of diabetic cats and dogs. The aim of this retrospective study was 
to evaluate the practical feasibility of and identify the major problems encountered with HMBG in 
diabetic pets. A standard questionnaire was filled in by owners of 9 diabetic pets monitored with 
HMBG. The need for more than 1 puncture to obtain a blood drop, the creation of a sufficient blood 
drop, the need for assistance in restraining the pet, and the resistance of the pet were the most 
frequently encountered problems during HMBG. The major obstacles for the owners to start with 
HMBG were also identified. In conclusion, HMBG is a practical and simple technique for most own-
ers and, overall, owners were satisfied.
Résumé — Étude rétrospective de la perception des propriétaires relativement à la surveillance 
à domicile de la glycémie chez les chiens et chats diabétiques. Depuis trois décennies, 
l’autosurveillance glycémique (ASG) a été recommandée pour réaliser le suivi des humains diabé-
tiques. Depuis quelques années, l’ASG est également devenue populaire dans le suivi des chiens ou 
chats atteints de diabète. Le but de cette étude rétrospective était d’évaluer la faisabilité et d’identifier 
les problèmes majeurs rencontrés avec l’ASG chez nos patients diabétiques. Un questionnaire standard 
a été rempli par les propriétaires de neuf animaux diabétiques réalisant le suivi du diabète grâce à 
l’ASG. La nécessité de réaliser plus d’une ponction par mesure, la création d’une goutte de sang 
suffisante, la nécessité d’une personne supplémentaire pour contentionner le patient étaient les pro-
blèmes rencontrés le plus fréquemment lors d’ASG. Les obstacles majeurs pour débuter l’ASG étaient 
également identifiés. En conclusion, l’ASG est techniquement facile à réaliser pour la plupart des 
clients et généralement ceux-ci étaient satisfaits d’appliquer ce type de suivi.
(Traduit par les auteurs)
Can Vet J 2005;46:718–723
Introduction
D iabetes mellitus is a commonly diagnosed endocrine disease in middle-aged to older dogs and cats. The 
diagnosis, based on the presence of appropriate clinical 
signs (polyuria, polydipsia, polyphagia, and weight loss), 
hyperglycemia, and glucosuria is most often straightfor-
ward (1). Treatment usually involves appropriate insulin 
therapy, an adapted diet, and exercise. The major goals 
of treating diabetic patients are to alleviate clinical signs 
of diabetes and to prevent complications, including 
hypoglycemia (2).
The difficulty with the disease resides in appropriate 
monitoring of therapy. The combination of history, 
physical examination, and changes in body weight is 
effective for initially assessing control of glycemia in 
diabetic dogs and cats. However, correlation between 
owner observations and glycemic control measured by 
laboratory findings was less reliable in cats compared 
with dogs (3,4).
The measurement of glucose in the urine, although 
easy to obtain, is not recommended. The Somogyi phe-
nomenon is a physiologic counter regulation following 
a hypoglycemic period (blood glucose  3.6 mmol/L) 
that results in persistent hyperglycemia for 24 to 72 h. 
Therefore, glucosuria can persist for several days follow-
ing insulin overdosage (1,2).
Serum fructosamine concentration reflects changes 
in serum glucose concentrations over the preceding 1 to 
3 wk (5). Both sensitivity and specificity of serum fruc-
tosamine concentrations for diagnosing diabetes mellitus 
in dogs are high, 0.93 and 0.95, respectively (6). When 
serum fructosamine is increased, it indicates poor glyce-
mic control, but it does not identify the underlying 
problem (1). Some diabetic dogs and cats can have nor-
mal serum fructosamine values, because in early- 
diagnosed diabetes mellitus, the duration or degree of 
elevated serum glucose concentrations is insufficient to 
raise fructosamine values above the reference range (7).
For all these reasons, serial blood glucose concentra-
tions (BGCs) are an excellent tool in evaluating the 
response of diabetic dogs and cats to insulin therapy. But 
even more importantly, serial BCGs allow identification 
of the cause of inadequate regulation. The results of 
serial BGCs, together with history and clinical signs, 
allow appropriate treatment adjustments to be made 
(1,2,8). However, several factors can influence the results 
Department of Medicine and Clinical Biology of Small 
Animals, Faculty of Veterinary Medicine, University of Ghent, 
Salisburylaan 133, B-9820 Merelbeke, Belgium.
Address all correspondence to Dr. Isabel Van de Maele; e-mail: 
Isabelvandemaele@hotmail.com
Reprints will not be available from the authors.
Can Vet J Volume 46, August 2005 719
of serial BGCs and, thus, the decisions made regarding 
insulin administration. Most important, 24 h of hospital-
ization is required. During the hospitalization period, 
differences in the feeding schedules and the amount of 
exercise of the diabetic pet are often encountered. Also, 
stress due to an unfamiliar environment or repeated vein 
punctures can lead to hyperglycemia, especially in cats 
(1). Furthermore, serial BGCs are often time-consuming 
and costly for the owner. For these reasons, BGCs are 
frequently performed less often then required (9,10).
In humans, self-monitoring of blood glucose (SMBG) 
was introduced in the late 1970s and is now widely rec-
ommended in type I and II diabetic patients who are 
pharmacologically treated (11–13). Self-monitoring of 
blood glucose has been shown to result in better glycemic 
control in humans (14–16).
In accordance with human medicine, capillary blood 
samples can be taken from the ear in pets (9,17,18) and 
blood glucose concentrations measured by using portable 
blood glucose meters (PBGM) (19,20). Most PBGMs 
require as little as 3 to 5 L of blood (21). Since home 
monitoring of blood glucose (HMBG) in pets is a fairly 
new procedure that has to be carried out by the owner, 
the purpose of this study was to evaluate retrospectively 
the practical feasibility and the major problems encoun-
tered with HMBG in diabetic pets.
Materials and methods
All owners performing HMBG between November 2001 
and February 2003 were included in the study. Their dogs 
and cats had been examined previously at the Department 
of Medicine and Clinical Biology of Small Animals at 
the Faculty of Veterinary Medicine, University of Ghent, 
Belgium, and diagnosed with diabetes mellitus, based 
on the occurrence of appropriate clinical symptoms 
(polyuria, polydipsia, polyphagia, and weight loss), 
increased fasting serum glucose values, and glucosuria. 
A complete blood (cell) count (CBC), a serum bio-
chemical panel with serum fructosamine concentrations, 
and a urinalysis with bacterial culture were performed 
as part of the routine evaluation of diabetic patients. All 
pets received insulin, SC, q12h, and individually adjusted 
dietary therapy.
The owners involved were educated on the treatment 
and other aspects of diabetes mellitus at the first consul-
tation. They also received instruction on the optimal use 
of the PBGM. The marginal ear vein technique was 
explained in detail and the owners were allowed to prac-
tise this technique under our supervision. The technique 
for HMBG most commonly taught to the owners in our 
hospital is illustrated in Figure 1.
First, the required equipment (bandage roll, needle or 
lancet device, PBGM, test strip, and gauze or cotton) is 
placed in close proximity to the pet. Second, after local-
ization of the marginal ear vein on the margins of the ear 
pinna and the creation of a stable background with a hard 
cylindrical shaped object, the vein is punctured with a 
needle or a lancet device. Third, after an adequate blood 
drop has formed, the PBGM is brought into contact with 
the drop and blood is absorbed on the test strip in the 
PBGM. Finally, while the PBGM is counting down for 
Figure 1. Marginal ear vein technique. The marginal ear vein is easily recognized in dogs and cats. In longhaired pets, a small 
part of the pinna can be shaved to obtain better visualization of the vein. A stable background is created with the use of a cylindri-
cal shaped object (bandage roll). The vein is punctured with a needle or a lancet device and a sufficient blood drop can be obtained. 
The use of alcohol on the ear as a disinfectant is not advised because of the risk of dispersing the blood drop. 
A portable blood glucose meter (PGBM) is used to measure blood glucose concentrations. The PBGM is fast (30 s) and easy to 
use, requiring as little as 3 to 5 L of blood. Afterwards pressure is applied on the punctured area to avoid excessive bleeding.
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30 s, gauze is pressed against the puncture site to stop 
the bleeding, if necessary.
Owners were advised to measure blood glucose con-
centrations before the administration of insulin and then 
every 2 h for a 12-h or 24-h period. All blood glucose 
concentrations were measured with PBGMs. Further 
controls and treatment adjustments were planned accord-
ing to the recommendations made by the clinician.
A standard questionnaire was sent by mail to all 
owners performing HMBG, after verbal approval was 
received by telephone. Twenty-four questions were 
divided into 5 sections. Each section contained a number 
of questions related to the following aspects: general 
information about the pet and the pet’s illness; the tech-
nique used for the generation of serial BGCs; the diffi-
culties encountered during HMBG, initially and current; 
the reasons for reluctance to start HMBG initially; and 
the perceived beneficial effects of HMBG by the owner 
for their pet. A summary of the questionnaire is given in 
Table 1.
Results
General information about the pet and the pet’s 
illness
Nine owners who were or had been performing HMBG 
between 2001 and 2003 were contacted, all 9 owners 
agreed to fill in the questionnaire. Seven dogs between 
7 and 14 y of age (mean 11 y) were included. The breeds 
represented were fox terrier, rottweiler, keeshond, Border 
collie, golden retriever, and mixed breed (n = 2). All 
5 female dogs were spayed and the 2 male dogs were 
intact. Two female spayed cats, a Blue Russian aged 
13 y and a mixed breed aged 15 y, were also included. 
The time period between the diagnosis, the start of treat-
ment of diabetes mellitus, and the beginning of HMBG 
ranged from 1 mo to 5 y (mean 14.5 mo). The number 
of serial BGCs performed per owner ranged from 1 to 8 
(mean 4). All pets were treated with insulin, SC, q12h, 
at an individually adjusted dose (initial starting dose 
0.5 U/kg body weight [BW], q12h). Eight pets received 
Caninsulin (Intervet, Boxmeer, the Netherlands) and 
1 cat received Mixtard 30/70 (Novo Nordisk, Alphen aan 
den Rijn, the Netherlands). Three of the 5 female dogs 
were spayed after diabetes mellitus had been diagnosed. 
Both cats were spayed at young ages (1 and 2 y). Two dogs 
had concurrent diseases. One dog had been diagnosed 
with primary epilepsy several years before diabetes mel-
litus was diagnosed and was treated with phenobarbital 
0.5 mg/kg BW, q12h and 1 female dog had a mammary 
gland tumor. Four of the 9 owners kept a logbook of their 
pet.
The technique used for generation of BGCs
Slight differences in the technique were noted in com-
parison with the technique described in Figure 1. These 
differences consisted of a slightly different preparation 
of the ear, the type of glucometer used, and the use of a 
lancet rather than a needle.
To prepare the ear, 4 owners shaved a part of the ear 
for better visualization of the marginal ear vein. Two 
owners cleaned and dried the ear before puncturing it. 
One owner applied gentle massage on the ear to achieve 
hyperemia. Most owners used the Glucometer elite 
(Bayer, Antwerp, Belgium), which is also the PBGM 
most commonly used in our hospital. Three owners used 
3 different PBGMs, Glucocard memory PC (Menarini, 
Ricerche Sud, Pomezia, Italy), Gluco Touch (Johnson 
and Johnson, Dilbeek, Belgium), and One Touch Basic 
(Johnson and Johnson, Dilbeek, Belgium). Four owners 
used needles to puncture the ear vein, 2 preferred to use 
the lancet enclosed with the PBGM.
The protocol used for the generation of BGCs was 
adjusted to the owner and the pet, mostly 24-h curves 
were made with measurement of blood glucose values 
every 2 h during daytime and every 2 to 3 h at night. One 
owner performed 12-h curves on occasion, namely, when 
the pet seemed clinically well controlled. One owner 
always performed 12-h curves.
The difficulties encountered during HMBG at start 
and current
The difficulties encountered more than 50 percent of the 
time with HMBG, initially, were the need for assistance 
in restraining the pet (n = 4), the need for more than 
1 puncture to obtain a blood drop due to pet resistance 
(n = 3), the creation of a blood drop of sufficient size 
(n = 3), and the resistance of the pet (n = 2). Later, at the 
time the questionnaire was filled in by the owner, 3 own-
ers had difficulties with the need for assistance, 2 owners 
encountered resistance of the pet, 1 owner needed more 
Table 1. The standard questionnaire: summary
1/ General information about the pet and the pet’s illness
 —  signalment
 —  diagnosis of diabetes mellitus
 —  treatment: type of insulin and dosage, diet, activity, logbook
 —  time between diagnosis and start of HMBG
 —  any concurrent illness
2/ The technique used for generation of BGCs
 —  type of PBGM, with lancet device or needle
 —  number of BCGs
 —  duration and time intervals of BCGs
 —  preparation of the ear
3/ The difficulties encountered during HMBG when starting and 
currently
 —  resistance of the pet
 —  restraining of the pet
 —  need for more than 1 puncture due to the resistance of the pet
 —  creation of a blood drop
 —  need for more than 1 puncture due to technical problems
 —  formation of visible puncture sites due to local hemorrhage
 —  absorption of blood on the test strip
 —  need for more than 1 test strip
 —  possible problems encountered with the PBGM
4/ The reasons for reluctance to start HMBG initially, including 
insufficient clarity, insufficient guidance, the responsibility, fear of 
hurting the pet, the complexity of the technique, blood sampling, 
the use of the PBGM, the costs, and the time required.
5/ The perceived beneficial effects of HMBG by the owner
 —  communication with the veterinarian
 —  evolution of the clinical signs
 —  subjective beneficial effects
 —  medical background or experience with diabetes mellitus of 
the owner
 —  any suggestions concerning HMBG
HMBG — Home monitoring of blood glucose; BGC — Blood glucose concen-
trations; PBGM — Portable blood glucose meter
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than 1 puncture to obtain a blood drop due to pet resis-
tance, and 1 encountered difficulties in creating a suf-
ficient blood drop more than 50 percent of the time. 
Other difficulties were seen less than 50 percent of the 
time with every blood glucose measurement. These 
included the need for more than 1 test strip (n = 7 at start, 
n = 5 later), the need for more than 1 puncture due to 
technical problems (n = 5 at start, n = 3 later), and inad-
equate absorption of the blood drop (n = 4 at start, n = 2 
later). A visible puncture site secondary to a local bleed-
ing was seen in only 1 dog. These results are summarized 
in Table 2.
Reasons for reluctance to start HMBG initially
The major reasons for the reluctance of the owners to 
start HMBG, initially, were the fear of hurting their pet 
(n = 5/9), taking a blood sample themselves (n = 4/9), 
and the costs involved (n = 4/9). Several owners also 
considered the complexity of the technique (n = 3/9) and 
the fact that HMBG is time-consuming (n = 3/9) as 
drawbacks of the technique. On the other hand, insuffi-
cient clarity about the technique or insufficient guidance, 
the responsibility involved, or the use of the PBGM were 
not considered to be obstacles for starting HMBG.
Subjective beneficial effects of HMBG
All owners believed HMBG helped in the glycemic con-
trol of their pet. This belief was based on the improve-
ment of the clinical signs of the pet, the stability of the 
pet’s overall condition, and the active participation of the 
owner in the management of his pet’s illness. Despite 
these conclusions, 2 of the owners preferred to have the 
serial BGCs performed by a veterinarian; both found 
HMBG to be too time-consuming and 1 of them was also 
afraid of hurting his pet too much.
Discussion
Self-monitoring of blood glucose concentrations is con-
sidered to be the most important step forward in the 
treatment of diabetic humans since the discovery of and 
the treatment with insulin (10). In this retrospective 
study, all owners were able to generate a blood glucose 
curve at home. A previous study conducted in healthy 
pets showed that 7/7 owners and 3/7 cat owners were able 
to generate a reliable blood glucose curve (10). Another 
recent study demonstrated that 10/12 owners of diabetic 
dogs were able to perform blood glucose curves at home 
(22). Good owner communication and education were 
essential in obtaining these results (10,22). Also, in 
human medicine, repeated educational sessions and 
proper patient guidance were essential in obtaining 
improved glycemic control in diabetic patients (11). The 
fact that all owners in this study were successful in com-
pleting a BGC at home was also due to owner selection 
and motivation. The concept of HMBG was only intro-
duced at our hospital when the clinician judged that 
treatment of diabetes mellitus was sufficiently understood 
by the owner. Also, owners were able to refuse HMBG 
and these pets were further evaluated in the hospital. 
Therefore, only highly motivated owners interested in 
performing HMBG were included in this study.
The need for assistance in restraining the pet was the 
problem most frequently encountered. However, mostly 
only 1 extra person was needed to keep the dog or the 
ear of the dog in a fixed position to facilitate blood drop 
formation and blood glucose measurement.
A comparison between the results in the beginning of 
HMBG and at the time the questionnaire was filled in 
gives an indication of the fact that fewer problems were 
encountered with increasing experience with the tech-
nique, in keeping with previous studies (10,22).
Casella et al (22) reported that the problems initially 
encountered with HMBG in diabetic dogs were the pro-
duction of the required negative pressure with the lancing 
device, the restraint of the dog, the production of a blood 
drop, the absorption of a blood drop, and the correct use 
of the test strips and the PBGM. In their study, a different 
technique to obtain a blood drop was described. An 
automatic lancing device that creates negative pressure, 
(Microlet Vaculance, Bayer Diagnostics, Zurich, 
Switzerland) was used to puncture the ear. Although this 
technique was described as the best method in obtaining 
capillary blood samples from the ear of a dog (10), it was 
also responsible for most of the initial problems, includ-
ing the fact that too much pressure was applied on the 
outer pinna by the owner, preventing the formation of an 
adequate blood drop. In our study, owners were taught 
Table 2. Overview of the results concerning the major problems encountered during 
home monitoring of blood glucose
 Never  50% of time  50% of time Always
Problems At start Now At start Now At start Now At start Now
Resistance of the pet 5 5 1 1 1 0 1 2
Several puncturesa 5 5 0 2 1 0 2 1
Extra person needed 4 5 0 0 0 0 4 3
Insufficient blood drop 3 3 3 3 3 1 0 0
Several puncturesb 2 4 4 3 1 0 0 0
Visible puncture site 7 6 1 1 0 0 0 0
Absorption blood 4 5 3 2 1 0 0 0
Additional strip needed 2 3 6 5 1 0 0 0
Problems with use of glucometer 6 5 1 1 0 0 1 0
The total of each problem does not always equal 9 because not all the questions were answered by all owners. For example, 
1 owner performed only 1 blood glucose concentrations (BGC) at home; therefore, the answers were considered to be in the 
beginning of home monitoring of blood glucose (HMBG) and were not added to the now-column.
aNeeded because of pet resistance
bNeeded because of technical problems
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to puncture the marginal ear vein, which can be identi-
fied visually in most dogs and cats. This technique is 
similar to the one described by Thompson et al (23). 
Because it is a vein that is being punctured, a blood drop 
forms quickly without the need for negative pressure. 
Therefore, the most important problem concerning 
HMBG encountered in other studies was avoided. The 
marginal ear vein technique could represent a more 
accessible technique for owners. This could influence the 
decision of the owner to start with HMBG in a positive 
way. In addition, the major problems initially encountered 
with HMBG were the use of the PBGM and the test strips 
(10,22). In this study, 7 owners needed extra punctures 
due to technical difficulties in the beginning of HMBG, 
but less than 50 percent of the time. This indicates that, 
although these problems were frequently encountered, 
they did not represent a major obstacle.
In accordance with other studies (9,10), the sites of 
blood collection were not painful and hardly visible. A 
visible puncture site caused by local bleeding was rec-
ognized after puncture in 1 dog (keeshond).
It became increasingly difficult to measure reliable 
glucose concentrations in 2 dogs (keeshond and fox 
terrier), because of increased resistance to the punc-
ture. Both owners of these dogs preferred to have the 
serial BGCs done by a veterinarian. In contrast, both 
cat owners reported that their cats became increas-
ingly tolerant with time, especially when the punc-
tures were performed at a place freely chosen by 
the cat.
The limitations of this study are that is was a retro-
spective study and different clinicians were involved in 
the follow-up of the patients. This also explains the slight 
differences seen in the technique used to perform HMBG 
and in the protocol used for HMBG. The clinician was 
also responsible for making the initial selection of own-
ers. Only owners who were considered to be accurately 
informed about all the aspects of diabetes mellitus were 
selected to perform HMBG. The results of this study 
should also be seen in light of the low case number. An 
additional fact that could have influenced the results is 
that 3 owners had some medical education: 1 owner was 
a nonpractising veterinarian and 2 were veterinary stu-
dents. Two owners had come in contact with human 
diabetic patients in their home environment.
This study also identified some fields to which special 
attention should be given in preparing an owner for 
HMBG. First, only 4/9 owners kept a logbook of their 
diabetic pet routinely. Recommendations to keep written 
information about the pet, including changes in appetite, 
attitude, body condition, water intake, urination, and 
body weight, have been made previously (1,5). A logbook 
is a helpful tool in long-term follow-up of the diabetic 
pet.
Second, good explanation concerning the PBGM and 
the test strips, including maintenance and calibration, is 
important. Most PBGMs are delivered with information 
brochures concerning maintenance and calibration. The 
owners should pay attention to it and the veterinarian 
should go through the important issues with the owner. 
Giving written handouts that cover all aspects on HMBG 
serve as a guideline and allow the owner to read through 
the procedure again.
Third, when owners are performing HMBG, easy 
access to veterinary consultation and advice should 
always be available. Good education leads to better com-
pliance and is associated with improved metabolic con-
trol in human and veterinary diabetics (10,16).
In diabetic dogs, serial blood glucose curves show 
significant day-to-day variability. In the study of Fleeman 
et al (24), significant differences in blood glucose mea-
surements were noted on 2 consecutive days when insu-
lin dose and meals were kept constant. Comparison of 
the BGCs obtained at day 1 with those on day 2 led to 
the same recommendations regarding insulin dose adjust-
ment in only 57% of cases. This implies important 
clinical implications, especially in well-controlled dogs. 
Therefore, appropriate treatment adjustments should be 
based on the results of serial BGCs, together with history 
and clinical signs (1,2,12). However, day-to-day vari-
ability of serial BGCs was seen in a hospital environment 
with the same disadvantages as discussed before, 
although special attention was paid to keep the amount 
of food constant each day (24). There are no studies so 
far that have looked at this aspect in a home environment.
Human studies show that self-monitoring of blood 
glucose by the diabetic patient is correlated with lower 
blood glycosylated hemoglobin concentrations (15,16). 
The effects of SMBG on patient morbidity and mortality, 
however, have not yet been evaluated. Few studies in dogs 
and cats have looked at this aspect. Twenty-eight cats 
controlled with HMBG received higher insulin doses 
compared with diabetic cats without HMBG, but the 
difference was not statistically significant (25). Therefore, 
further studies are needed to confirm that HMBG 
is really effective in improving glycemic regulation in 
diabetic cats and dogs.
One of the major problems encountered with SMBG 
in humans is limited compliance with the technique 
(11). The SMBG is an invasive method. The fingertips 
of humans contain high numbers of nerve endings and 
therefore repeated pricking is associated with a painful 
sensation. Also, the cost to be paid by the patient was an 
obstacle for good compliance. Only 1 veterinary study 
has looked at the compliance with HMBG in owners of 
diabetic cats (25). In this study, the long-term compliance 
with HMBG was considered good and client binding 
was not altered. However, identical obstacles to those in 
humans can be expected with pets. Continuous glucose 
monitors have been developed for use in human diabetics 
(26,27). Minimally invasive glucose sensors are placed 
on the skin and interstitial fluid glucose concentrations 
are measured. Besides detecting fluctuations in blood 
glucose over a prolonged period, these sensors no lon-
ger require repeated punctures. A continuous glucose 
monitoring system was evaluated in 10 cats with diabetes 
mellitus (28). Mostly the device was well tolerated and 
able to generate a continuous glucose curve. However, 
stress hyperglycemia and the working range of the moni-
tor (between 2.2 to 22.2 mmol/L) limited its practical 
use.
In conclusion, a slightly different technique to produce 
serial BCGs at home is described here. Also some fields 
requiring special attention while applying HMBG are 
identified. For most owners, HMBG is a feasible tech-
nique and is relatively easy to perform, especially if 
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adequate education of the owner by the veterinarian is 
provided. Furthermore most pets seem to tolerate it well. 
Therefore, it represents a useful tool in the follow-up of 
diabetic pets.
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